Aileron Therapeutics, Inc. - stock earnings
ALRN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.8 million USD | ? USD |
| 2023Q2 | -1.8 million USD | ? USD |
| 2023Q1 | -4.5 million USD | ? USD |
| 2022Q4 | -4.4 million USD | ? USD |
| 2022Q3 | -6.3 million USD | ? USD |
| 2022Q2 | -7.9 million USD | ? USD |
| 2022Q1 | -8.4 million USD | ? USD |
| 2021Q4 | -6.8 million USD | ? USD |
| 2021Q3 | -6.7 million USD | ? USD |
| 2021Q2 | -5.7 million USD | ? USD |
| 2021Q1 | -7.0 million USD | ? USD |
| 2020Q4 | -5.0 million USD | ? USD |
| 2020Q3 | -5.0 million USD | ? USD |
| 2020Q2 | -4.4 million USD | ? USD |
| 2020Q1 | -6.7 million USD | ? USD |
| 2019Q4 | -7.2 million USD | ? USD |
| 2019Q3 | -7.7 million USD | ? USD |
| 2019Q2 | -7.2 million USD | ? USD |
| 2019Q1 | -7.2 million USD | ? USD |
| 2018Q4 | -7.0 million USD | ? USD |
| 2018Q3 | -7.4 million USD | ? USD |
| 2018Q2 | -9.5 million USD | ? USD |
| 2018Q1 | -6.9 million USD | ? USD |
| 2017Q4 | -6.9 million USD | ? USD |
| 2017Q3 | -6.3 million USD | ? USD |
| 2017Q2 | -4.9 million USD | ? USD |
| 2017Q1 | -4.6 million USD | ? USD |
| 2016Q4 | -4.4 million USD | ? USD |
| 2016Q3 | -4.2 million USD | ? USD |
| 2016Q2 | -5.5 million USD | ? USD |
| 2016Q1 | -3.9 million USD | ? USD |
| 2015Q4 | -12.9 million USD | ? USD |
ALRN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -12.9 million USD | ? USD |
| 2022 | -27.0 million USD | ? USD |
| 2021 | -25.8 million USD | ? USD |
| 2020 | -21.8 million USD | ? USD |
| 2019 | -28.8 million USD | ? USD |
| 2018 | -31.5 million USD | ? USD |
| 2017 | -22.6 million USD | ? USD |
| 2016 | -18.1 million USD | ? USD |
| 2015 | -12.9 million USD | ? USD |
| 2014 | -16.0 million USD | ? USD |
ALRN
Price: $3.76
52 week price:
Earnings Per Share: -2.85 USD
P/E Ratio: -1.64
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 28786
Ebitda: -6.4 millionMarket Capitalization: 26.1 million